Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Operating Cash Flow (Statement)

Latest reported-$9.51Mperiod endingJun 30, 2026

CANF TTM Cash from Operations (-$5.49M → -$9.51M)

TTM operating cash flow (statement)

High-resolution chart · PNG

CANF operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2026	-9,511,000
Mar 31, 2026	-9,230,000
Dec 31, 2025	-8,949,000
Sep 30, 2025	-8,651,000
Jun 30, 2025	-8,353,000
Mar 31, 2025	-7,994,999
Dec 31, 2024	-7,636,998
Sep 30, 2024	-5,836,498
Jun 30, 2024	-4,130,998
Mar 31, 2024	-2,017,999
Dec 31, 2023	0
Sep 30, 2023	263,000
Jun 30, 2023	223,000
Mar 31, 2023	263,000
Dec 31, 2022	263,000
Sep 30, 2022	0
Jun 30, 2022	135,000
Mar 31, 2022	0
Dec 31, 2021	0
Sep 30, 2021	0
Jun 30, 2021	0
Mar 31, 2021	0
Dec 31, 2020	0
Sep 30, 2020	0
Jun 30, 2020	0
Mar 31, 2020	0
Dec 31, 2019	0
Sep 30, 2019	0
Jun 30, 2019	0
Mar 31, 2019	0
Dec 31, 2018	0
Sep 30, 2018	0
Jun 30, 2018	0
Mar 31, 2018	0
Dec 31, 2017	0
Sep 30, 2017	0
Jun 30, 2017	0
Mar 31, 2017	0
Dec 31, 2016	0
Sep 30, 2016	0
Jun 30, 2016	0
Mar 31, 2016	0
Dec 31, 2015	0
Sep 30, 2015	0
Jun 30, 2015	0
Mar 31, 2015	0
Dec 31, 2014	0
Sep 30, 2014	-2,807,975
Jun 30, 2014	-4,400,188
Mar 31, 2014	-6,044,085
Dec 31, 2013	-8,533,657
Sep 30, 2013	-6,757,156
Jun 30, 2013	-5,959,049
Mar 31, 2013	-5,715,566
Dec 31, 2012	-4,425,773
Sep 30, 2012	-4,586,748
Jun 30, 2012	-4,609,665
Mar 31, 2012	-4,832,522
Dec 31, 2011	-5,489,677
Sep 30, 2011	-4,969,186